| 000 | 01835 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516080044.0 | ||
| 264 | 0 | _c20120511 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1879-355X | ||
| 024 | 7 |
_a10.1016/j.ijrobp.2011.11.038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoref, Cheryl M | |
| 245 | 0 | 0 |
_aA new orally active, aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cApr 2012 |
||
| 300 |
_ae701-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAmifostine _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiamines _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFerrets |
| 650 | 0 | 4 |
_aHypotension _xchemically induced |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aRadiation Injuries, Experimental _xprevention & control |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aHacker, Timothy A | |
| 700 | 1 | _aFahl, William E | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 82 _gno. 5 _gp. e701-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2011.11.038 _zAvailable from publisher's website |
| 999 |
_c21542107 _d21542107 |
||